S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NYSE:CLBCore Laboratories Stock Price, Forecast & News

$24.46
+0.09 (+0.37 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$23.94
Now: $24.46
$25.02
50-Day Range
$19.37
MA: $21.73
$24.93
52-Week Range
$6.68
Now: $24.46
$52.13
Volume434,300 shs
Average Volume1.33 million shs
Market Capitalization$1.09 billion
P/E RatioN/A
Dividend Yield0.16%
Beta3.03
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Read More
Core Laboratories logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars


Industry, Sector and Symbol

Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
CUSIPN/A
Phone31-20-420-3191

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$668.21 million
Cash Flow$2.40 per share
Book Value$4.10 per share

Profitability

Net Income$101.98 million

Miscellaneous

Employees4,300
Market Cap$1.09 billion
Next Earnings Date10/28/2020 (Estimated)
OptionableOptionable
$24.46
+0.09 (+0.37 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Core Laboratories (NYSE:CLB) Frequently Asked Questions

How has Core Laboratories' stock price been impacted by Coronavirus (COVID-19)?

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CLB shares have increased by 123.8% and is now trading at $24.46.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Core Laboratories?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 11 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Core Laboratories
.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Core Laboratories
.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) released its quarterly earnings data on Wednesday, July, 22nd. The oil and gas company reported $0.14 earnings per share for the quarter, topping analysts' consensus estimates of $0.10 by $0.04. The oil and gas company had revenue of $115.74 million for the quarter, compared to the consensus estimate of $115.43 million. Core Laboratories had a positive return on equity of 46.27% and a negative net margin of 13.39%.
View Core Laboratories' earnings history
.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories announced a quarterly dividend on Friday, July 17th. Shareholders of record on Monday, July 27th will be given a dividend of $0.01 per share on Monday, August 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Friday, July 24th.
View Core Laboratories' dividend history
.

What price target have analysts set for CLB?

14 brokers have issued 12 month price objectives for Core Laboratories' shares. Their forecasts range from $11.00 to $48.00. On average, they expect Core Laboratories' share price to reach $26.96 in the next twelve months. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for Core Laboratories
.

Has Core Laboratories been receiving favorable news coverage?

Media coverage about CLB stock has been trending extremely negative on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Core Laboratories earned a daily sentiment score of -4.1 on InfoTrie's scale. They also gave news stories about the oil and gas company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days.
View the latest news about Core Laboratories
.

Are investors shorting Core Laboratories?

Core Laboratories saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 5,470,000 shares, a decrease of 33.7% from the June 15th total of 8,250,000 shares. Based on an average daily volume of 1,450,000 shares, the days-to-cover ratio is presently 3.8 days. Currently, 12.5% of the company's stock are sold short.
View Core Laboratories' Short Interest
.

Who are some of Core Laboratories' key competitors?

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Chipotle Mexican Grill (CMG), Endologix (ELGX), Micron Technology (MU), AT&T (T), Baidu (BIDU), Gilead Sciences (GILD) and Netflix (NFLX).

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the following people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
  • Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
  • Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by many different retail and institutional investors. Top institutional shareholders include AKO Capital LLP (2.99%), Goldman Sachs Group Inc. (2.75%), Fisher Asset Management LLC (2.04%), Douglas Lane & Associates LLC (0.95%), Principal Financial Group Inc. (0.87%) and Morningstar Investment Services LLC (0.86%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories
.

Which major investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Bank of New York Mellon Corp, Bank of Montreal Can, American International Group Inc., Mutual of America Capital Management LLC, WINTON GROUP Ltd, Fisher Asset Management LLC, and Kopion Asset Management LLC.
View insider buying and selling activity for Core Laboratories
.

Which major investors are buying Core Laboratories stock?

CLB stock was purchased by a variety of institutional investors in the last quarter, including AKO Capital LLP, Morningstar Investment Services LLC, Principal Financial Group Inc., First Trust Advisors LP, Macquarie Group Ltd., Natixis Advisors L.P., Douglas Lane & Associates LLC, and FMR LLC. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno.
View insider buying and selling activity for Core Laboratories
.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $24.46.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $1.09 billion and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe.

What is Core Laboratories' official website?

The official website for Core Laboratories is www.corelab.com.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.